Northern Cancer Institute

Recent papers from Northern Cancer Institute

1. Multifocal Glioblastoma Managed With Primary Temozolomide as a Strategy to Delay Radiation Therapy: Clinical and Radiological OutcomesAsia-Pacific Journal of Clinical Oncology · 2026
2. Experiences of Aboriginal Young People, Families and Carers as They Transition From children's to Adult Health Services in NSWJournal of Paediatrics and Child Health · 2026
3. Progressive lateral femoral condyle lengthening in total knee arthroplasty produces dose‐dependent increases in patellofemoral joint loading and alters patellar trackingKnee Surgery Sports Traumatology Arthroscopy · 2026
4. Real‐world outcomes in patients with hormone receptor positive, human epidermal growth factor receptor 2 receptor‐negative advanced breast cancer and visceral metastases at baseline – advanced hormone receptor positive breast cancer registry in AustraliaInternal Medicine Journal · 2026
5. Tirzepatide Is Associated With Improved Metabolic Outcomes in People With Type 1 Diabetes and Overweight or Obesity: A Retrospective Cohort StudyDiabetes Obesity and Metabolism · 2026
6. Changes in the metabolome after treatment with canagliflozin in patients with type 2 diabetes.2026
7. MAGMA: Multi-arm glioblastoma Australasia phase 3 trial.Journal of Clinical Oncology · 2026
8. Antenatal management of HNF4A-MODY and INSR mutations in pregnancy.2026
9. Not a Standalone Treatment: Considerations for Psychedelic‐Assisted TherapyBrain and Behavior · 2026
10. Utility of dynamic 18F-FET PET in determining pseudoprogression from tumour recurrence in the six months following radiation therapy for glioblastomaNeuro-Oncology Advances · 2026
11. Who can hold their breath? understanding individual patient’s needs and screening for deep inspiration breath hold (DIBH) suitability in rural cancer care: a retrospective evaluationTechnical Innovations & Patient Support in Radiation Oncology · 2026
12. Assessment of Patterns of Infiltration and Relapse of Patients with Glioblastoma of the Occipital LobeBrain Sciences · 2026
13. Estimating the number of people living with metastatic breast cancer: a population-based retrospective cohort study using linked health dataThe Lancet Regional Health - Western Pacific · 2026
14. Abstract PS3-11-04: Adjuvant Ado-Trastuzumab Emtansine (T-DM1) for Older Patients with HER2+ Breast Cancer - Results from the ATOP StudyClinical Cancer Research · 2026
15. Abstract PS2-02-29: Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia - ARORA RegistryClinical Cancer Research · 2026
16. Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin–naïve Non–muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301)European Urology · 2026
17. Increased mROS Generation Associates With Cardiovascular Risk in BioHEART ‐ CT PBMCsClinical and Translational Science · 2026
18. Intervertebral Disc Proteoglycans: Multifunctional Tissue Stabilizing and Instructional Cell Regulatory Proteins That Control Tissue HomeostasisJOR Spine · 2025
19. The Impact of the Ovine Annular Lesion Model on IVD Pathobiology and Utility of the Ovine Spinal Model in Patho‐Anatomical Studies: A Historical PerspectiveJOR Spine · 2025
20. Glucagon‐like peptide‐1 receptor agonist treatment reduces body weight and improves glycaemic outcomes in patients with concurrent overweight/obesity and type 1 diabetes: A systematic review and meta‐analysisDiabetes Obesity and Metabolism · 2025